CEO/ Founder of Sharpline Life Sciences | Language & Communication Consultant | Scientific Communications Specialist | Healthcare Consultant
Clinical research runs on data, protocols, and precision. Billions of dollars are spent ensuring molecules behave exactly as expected. Yet the entire system relies on a fragile assumption that the humans involved actually understand what they are reading. When trials fail, timelines stretch, or patients drop out, the industry often blames science or logistics. The truth is usually much simpler and much harder to fix. The breakdown happens the moment one person tries to explain something complex to another.
Beyond the Mechanics of Translation
Laura Rolfi is the CEO of Sharpline Life Sciences, a communication consultancy specializing in healthcare and clinical research. She steps into spaces where highly educated professionals assume communication is already solved, only to reveal the structural cracks beneath their workflows. Her defining trait is a refusal to treat understanding as a soft skill, viewing it instead as the critical infrastructure that determines whether global medicine actually works.
A Foundation Built on Systems, Not Just Syntax
The realization that language is a system, rather than just a collection of words, started in academia. Laura Rolfi spent over a decade as a university lecturer at the National University of Córdoba in Argentina. She taught contrastive grammar and reading comprehension to medical and dental students. Academia demanded intellectual curiosity and rigorous analysis. It forced her to question established frameworks and challenge assumptions about how information moves between minds.
She did not stay confined to the classroom. While teaching, she built a parallel career as a freelance translator and quality manager, eventually taking on senior linguistic roles. She saw firsthand how theoretical ideas collided with the reality of tight deadlines and corporate silos. She noticed a pattern across pharmaceutical companies and contract research organizations. Projects were constantly delayed. Risks were overlooked. People were excluded from crucial healthcare decisions.
The missing ingredient was almost never technical expertise. It was clarity. By 2013, she founded Sharpline to address this exact gap. She realized that translation alone was a bandage over a deeper wound. The real problem was a failure to design information with the end user in mind. She shifted her focus from localizing text to redesigning the systems that produce it. Her leadership eventually expanded into broader industry advocacy, including board and management roles with Women in Localization and the Argentine Language Industry Association.
Making Understanding an Operational Imperative
Today, Laura Rolfi is focused on moving communication out from the shadow of administrative support. She partners with clinical research organizations, sponsors, and healthcare companies to integrate clarity into the very design of their trials. Her team handles high-stakes multilingual documentation, but their true value lies in fixing the operational chaos that surrounds it. She targets the systemic failures that occur when linguists, clinicians, and project managers work in isolation.
“I don’t see communication as a support function,” Rolfi says. “I see it as part of the infrastructure that determines whether clinical research runs efficiently, safely, and ultimately reaches patients.” When a global CRO needed to deliver documentation across multiple countries under severe time constraints, her intervention went far beyond linguistic accuracy. She established terminology governance before production even began.
She separated linguistic, scientific, regulatory and formatting reviews into distinct quality layers. This operational overhaul centralized decision-making and gave the client absolute confidence in the traceability of every deliverable. “I’ve learned that most communication failures aren’t caused by language,” she explains. “They’re caused by fragmented ownership.” By fixing the ownership problem, she eliminates the ambiguity that creates expensive downstream risks.
Her approach demands that everyone understands the purpose of the content, not just their individual task. She measures success by a single, unforgiving metric. “If a patient, investigator, or healthcare professional struggles to understand it, we haven’t finished the job,” she states. This philosophy ensures that accessibility is treated as a deliberate outcome rather than an accidental byproduct.
This rigorous perspective extends to her view on technology in the life sciences sector. As organizations rush to adopt artificial intelligence, she cautions against using automation to replace human judgment. “The goal isn’t human oversight after the fact,” Rolfi notes. “It’s human steer throughout the process.” She believes technology should accelerate repetitive work and identify patterns, leaving the accountability for patient safety and scientific integrity firmly in human hands.
The True Cost of Ambiguity
The clinical research industry will always rely on complex science and rigorous protocols. But the success of those protocols depends entirely on whether the people executing them understand the assignment. Laura Rolfi has spent her career proving that clarity is not a luxury, nor is it a final polish applied at the end of a project. It is the foundation of equity, safety, and progress. When the machinery of global healthcare finally prioritizes understanding, the results speak for themselves.
Laura Rolfi is the CEO of Sharpline Life Sciences based in the Cordoba, Argentina Metropolitan Area. She helps healthcare and clinical research organizations connect globally through clear, accessible communication. To connect with Laura or learn more, visit her LinkedIn at linkedin.com/in/laurarolfi.
